| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.033 | 0.5 |